Scotland approves six new medicines including Tafamidis for treatment of rare heart condition
Pfizer data suggested that their drug would lead to improvements in 'mortality and fewer hospitalisations' for patients with this terrible conditionÂ
The Scottish Medicines Consortium...
SMC approves bulevirtide for treatment of chronic HDV infection in Scottish patients
Gilead Sciences has announced that the Scottish Medicines Consortium (SMC) has become the first UK health authority to permit routine NHS use of Hepcludex...
Scottish Medicines Consortium accepts upadacitinib to treat Active Ulcerative Colitis in Adults
The Scottish Medicines Consortium (SMC) has accepted AbbVie‘s RINVOQ (upadacitinib) for use within NHS Scotland for the treatment of adult patients with moderately to...